Suppressor of cytokine signaling 1 (SOCS1), by negatively regulating the Janus kinase (JAK)/signal transducer and activator of transcription (STAT) signaling pathway, inhibits the accumulation of central memory T cells and Teff subsets in cancer and has been identified as an optimal T cell enhancement target. The gene discussed is SOCS1; the disease is cancer.